IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness
Open accessAbstract
Interleukin-1 (IL-1) stimulation leads to the recruitment of interleukin-1 receptor-associated kinase (IRAK) to the IL-1 receptor, where IRAK is phosphorylated, ubiquitinated, and eventually degraded. Kinase-inactive mutant IRAK is still phosphorylated in response to IL-1 stimulation when it is transfected into IRAK-deficient cells, suggesting that there must be an IRAK kinase in the pathway. The fact that IRAK4, another IRAK family member necessary for the IL-1 pathway, is able to phosphorylate IRAK in vitro suggests that IRAK4 might be the IRAK kinase. However, we now found that the IRAK4 kinase-inactive mutant had the same ability as the wild-type IRAK4 in restoring IL-1-mediated signaling in human IRAK4-deficient cells, including NFkappaB-dependent reporter gene expression, the activation of NFkappaB and JNK, and endogenous IL-8 gene expression. These results strongly indicate that the kinase activity of human IRAK4 is not necessary for IL-1 signaling. Furthermore, we showed that the kinase activity of IRAK4 was not necessary for IL-1-induced IRAK phosphorylation, suggesting that IRAK phosphorylation can probably be achieved either by autophosphorylation or by trans-phosphorylation through IRAK4. In support of this, only the impairment of the kinase activity of both IRAK and IRAK4 efficiently abolished the IL-1 pathway, demonstrating that the kinase activity of IRAK and IRAK4 is redundant for IL-1-mediated signaling. Moreover, consistent with the fact that IRAK4 is a necessary component of the IL-1 pathway, we found that IRAK4 was required for the efficient recruitment of IRAK to the IL-1 receptor complex.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IRAK4's scaffolding role in Toll-like receptor signalling around the myddosome is established.
“Particularly for IRAK4, its scaffolding role in Toll-like receptor (TLR) signalling around the myddosome is established165,172”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · see citing works
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137 · see citing works
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622 · see citing works
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 3,380 · see citing works
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M. S., Mann, M., Manning, A. M., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,042 · see citing works
A family of human receptors structurally related to Drosophila Toll.
Rock, F., Hardiman, G., Timans, J., Kastelein, R., & Bazan, J. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.2.588 · Cited by 2,009 · see citing works
Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,814 · see citing works
TRAF6 is a signal transducer for interleukin-1
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305 · see citing works
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.
Wesche, H., Henzel, W., Shillinglaw, W., Li, S., & Cao, Z.-D. (1997) · Immunity · doi:10.1016/s1074-7613(00)80402-1 · Cited by 1,247 · see citing works
Ninomiya‐Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,187 · see citing works
IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK
Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., & Goeddel, D. V. (1997) · Science · doi:10.1126/science.278.5339.866 · Cited by 1,183 · see citing works
Identification and Characterization of an IκB Kinase
Régnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., & Rothe, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80344-x · Cited by 1,176 · see citing works
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., et al. (2002) · Nature · doi:10.1038/nature01182 · Cited by 995 · see citing works
IRAK: A Kinase Associated with the Interleukin-1 Receptor
Cao, Z., Henzel, W. J., & Gao, X. (1996) · Science · doi:10.1126/science.271.5252.1128 · Cited by 898 · see citing works
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A. C., Itié, A., Li, S., et al. (2002) · Nature · doi:10.1038/nature736 · Cited by 858 · see citing works
Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency
Pïcard, C., Puel, A., Bonnet, M., Ku, C., Bustamante, J. C., Yang, K., Soudais, C., Boisson‐Dupuis, S., Feinberg, J. M., Fieschi, C., et al. (2003) · Science · doi:10.1126/science.1081902 · Cited by 828 · see citing works
Self-citationIRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
Li, S., Strelow, A., Fontana, E. J., & Wesche, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082100399 · Cited by 714 · see citing works
Janssens, S., & Beyaert, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00053-4 · Cited by 559 · see citing works
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K. P., Tschopp, J., & Volpe, F. (2000) · Nature Cell Biology · doi:10.1038/35014038 · Cited by 554 · see citing works
TLR6: A novel member of an expanding Toll-like receptor family
Takeuchi, O., Kawai, T., Sanjo, H., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Takeda, K., & Akira, S. (1999) · Gene · doi:10.1016/s0378-1119(99)00098-0 · Cited by 429 · see citing works
Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.
Chuang, T., & Ulevitch, R. J. (2000) · PubMed · Cited by 402 · see citing works
Jiang, Z., Ninomiya‐Tsuji, J., Qian, Y., Matsumoto, K., & Li, X. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7158-7167.2002 · Cited by 284 · see citing works
Self-citationMedvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C. G., Salkowski, C. A., Zhang, S., Arditi, M., Gallin, J. I., & Vogel, S. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030701 · Cited by 262 · see citing works
Li, X.-X., Commane, M., Burns, C., Vithalani, K. K., Cao, Z.-D., & Stark, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4643 · Cited by 253 · see citing works
Self-citationT1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family
Mitcham, J. L., Parnet, P., Bonnert, T. P., Garka, K. E., GERHART, M. J., Slack, J. L., Gayle, M. A., Dower, S., & Sims, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5777 · Cited by 210 · see citing works
Towards an understanding of the signal transduction pathways for interleukin 1
O'Neill, L. A. J. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)00217-3 · Cited by 121 · see citing works
Molecular Mechanisms Underlying the Actions of the Pro-inflammatory Cytokine Interleukin I
O'Neill, L. A. J. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250295 · Cited by 27 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, J. F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 588 -593
- O'Neill, L. A. (1997) Biochem. Soc. Trans. 25, 295-302
- Li, S., Strelow, A., Fontana, E. J., and Wesche, H. (2002) Proc. Natl. Acad. Sci.
Cited by
Sorted by citations
PROTAC targeted protein degraders: the past is prologue
Békés, M., Langley, D. R., & Crews, C. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00371-6 · Cited by 3,395 · see citing works
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science s STKE · doi:10.1126/stke.3572006re13 · Cited by 1,269 · see citing works
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254 · see citing works
Targeted protein degradation: mechanisms, strategies and application
Zhao, L., Zhao, J., Zhong, K., Tong, A., & Jia, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00966-4 · Cited by 986 · see citing works
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 666 · see citing works
Doyle, S., & O'Neill, L. A. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.010 · Cited by 594 · see citing works
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488 · see citing works
TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
Verstrepen, L., Bekaert, T., Chau, T., Tavernier, J. H., Chariot, A., & Beyaert, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8064-8 · Cited by 440 · see citing works
Ku, C., von Bernuth, H., Pïcard, C., Zhang, S., Chang, H., Yang, K., Chrabieh, M., Issekutz, A. C., Cunningham, C. K., Gallin, J. I., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070628 · Cited by 399 · see citing works
Self-citationThe interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
Flannery, S. M., & Bowie, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.020 · Cited by 316 · see citing works
Plant and Animal Pathogen Recognition Receptors Signal through Non-RD Kinases
Dardick, C. D., & Ronald, P. C. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020002 · Cited by 275 · see citing works
A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity
Kim, T. W., Staschke, K. A., Bulek, K., Yao, J., Peters, K. L., Oh, K., Vandenburg, Y. R., Xiao, H. Q., Wen, Q., Hamilton, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061825 · Cited by 273 · see citing works
Self-citationIRAK1: A critical signaling mediator of innate immunity
Gottipati, S., Rao, N. L., & Fung‐Leung, W. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.009 · Cited by 269 · see citing works
Toll‐like receptors – sentries in the B‐cell response
Bekeredjian-Ding, I., & Jego, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03173.x · Cited by 249 · see citing works
Conze, D. B., Wu, C.-J., Thomas, J. A., Landstrom, A., & Ashwell, J. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02098-07 · Cited by 237 · see citing works
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
Carmody, R. J., & Chen, Y. H. (2007) · PubMed · Cited by 231 · see citing works
Understanding early TLR signaling through the Myddosome
Balka, K. R., & Nardo, D. D. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-096r · Cited by 192 · see citing works
Innate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 194 · see citing works
Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S., Takeuchi, O., & Akira, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061523 · Cited by 187 · see citing works
Rhyasen, G. W., & Starczynowski, D. T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.513 · Cited by 176 · see citing works
Nardo, D. D., Balka, K. R., Gloria, Y. C., Rao, V. R., Latz, E., & Masters, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003314 · Cited by 156 · see citing works
Signalling of Toll-Like Receptors
Brikos, C., & O'Neill, L. A. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_2 · Cited by 156 · see citing works
Lye, E., Mirtsos, C., Suzuki, N., Suzuki, S., & Yeh, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402666200 · Cited by 144 · see citing works
Targeting IRAK4 for Degradation with PROTACs
Nunes, J., McGonagle, G. A., Eden, J., Kiritharan, G., Touzet, M., Lewell, X., Emery, J., Eidam, H., Harling, J. D., & Anderson, N. A. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00219 · Cited by 134 · see citing works
Regulation of innate immune signaling by IRAK proteins
Pereira, M. C. A., & Gazzinelli, R. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133354 · Cited by 134 · see citing works
The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways
Pereira, M. C. A., Durso, D. F., Bryant, C. E., Kurt‐Jones, E. A., Silverman, N. S., Golenbock, D. T., & Gazzinelli, R. T. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111225 · Cited by 126 · see citing works
Huang, Y., Li, T., Sane, D. C., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410369200 · Cited by 125 · see citing works
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126 · see citing works
Yao, J., Kim, T. W., Qin, J., Jiang, Z., Qian, Y., Xiao, H. Q., Lu, Y., Wen, Q., Gulen, M. F., Sizemore, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609039200 · Cited by 117 · see citing works
Self-citationLu, T., Tian, L., Han, Y., Vogelbaum, M., & Stark, G. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700118104 · Cited by 113 · see citing works
Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S. M., Pass, A. K., Nuchtern, J. G., Zhang, D., Fu, S., Schneider, M. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802825200 · Cited by 112 · see citing works
Chaudhary, D., Robinson, S. D., & Romero, D. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5016044 · Cited by 108 · see citing works
Pellino Proteins: Novel Players in TLR and IL‐1R Signalling
Schauvliege, R., Janssens, S., & Beyaert, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00040.x · Cited by 100 · see citing works
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Bennett, J., & Starczynowski, D. T. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000693 · Cited by 100 · see citing works
Winkler, A. R., Sun, W., De, S., Jiao, A., Sharif, M., Symanowicz, P. T., Athale, S., Shin, J. H., Wang, J., Jacobson, B. A., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41953 · Cited by 93 · see citing works
TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent
Qin, J., Yao, J., Cui, G., Xiao, H. Q., Kim, T. W., Frączek, J., Wightman, P. D., Sato, S., Akira, S., Puel, A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512908200 · Cited by 93 · see citing works
Self-citationXiong, Y., Qiu, F., Piao, W., Song, C. H., Wahl, L. M., & Medvedev, A. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182873 · Cited by 90 · see citing works
Koziczak‐Holbro, M., Joyce, C., Glück, A., Kinzel, B., Müller, M., Tschopp, C., Mathison, J. C., Davis, C. N., & Gram, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700548200 · Cited by 90 · see citing works
Wan, Y., Xiao, H. Q., Affolter, J. T., Kim, T. W., Bulek, K., Chaudhuri, S., Carlson, D., Hamilton, T. A., Mazumder, B., Stark, G. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807822200 · Cited by 89 · see citing works
Self-citationTAK1 mediates convergence of cellular signals for death and survival
Aashaq, S., Batool, A., & Andrabi, K. I. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1490-7 · Cited by 85 · see citing works
Maitra, U., Gan, L., Chang, S., & Li, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003300 · Cited by 82 · see citing works
Sun, J., Li, N., Oh, K., Dutta, B., Vayttaden, S. J., Lin, B., Ebert, T. S., Nardo, D. D., Davis, J., Bagirzadeh, R., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab2191 · Cited by 82 · see citing works
Ntoufa, S., Vilia, M. G., Σταματόπουλος, Κ., Ghia, P., & Muzio, M. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.07.001 · Cited by 81 · see citing works
Armaroli, G., Verweyen, E. L., Pretzer, C., Kessel, K., Hirono, K., Ichida, F., Okabe, M., Cabral, D. A., Foell, D., Brown, K. L., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40784 · Cited by 78 · see citing works
IRAK4 in TLR/IL‐1R signaling: Possible clinical applications
Li, X. (2008) · European Journal of Immunology · doi:10.1002/eji.200838161 · Cited by 77 · see citing works
Self-citationRegulation of IRAK-4 kinase activity via autophosphorylation within its activation loop
Cheng, H., Addona, T. A., Keshishian, H., Dahlstrand, E. N., Lu, C., Dorsch, M., Li, Z., Wang, A., Ocain, T. D., Li, P., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.068 · Cited by 76 · see citing works
Ferrao, R., Li, J., Bergamin, E., & Wu, H. (2012) · Science Signaling · doi:10.1126/scisignal.2003124 · Cited by 75 · see citing works
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma
Fultang, L., Gamble, L. D., Gneo, L., Berry, A. M., Egan, S. A., de Bie, F. J., Yogev, O., Eden, G. L., Booth, S., Brownhill, S. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2139 · Cited by 70 · see citing works
IRAK-4 – a shared NF-κB activator in innate and acquired immunity
Suzuki, N., & Saito, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.003 · Cited by 67 · see citing works
Cushing, L., Stochaj, W. R., Siegel, M. M., Czerwiński, R., Dower, K., Wright, Q. G., Hirschfield, M., Casanova, J., Pïcard, C., Puel, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544809 · Cited by 65 · see citing works
Self-citationSong, K. W., Talamás, F. X., Suttmann, R. T., Olson, P. S., Barnett, J. W., Lee, S. W., Thompson, K., Jin, S., Hekmat-Nejad, M., Cai, T. Z., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.012 · Cited by 61 · see citing works
Chiang, E. Y., Yu, X., & Grogan, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002821 · Cited by 61 · see citing works
Frączek, J., Kim, T. W., Xiao, H., Yao, J., Wen, Q., Li, Y.-L., Casanova, J., Pryjma, J., & Li, X.-X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804779200 · Cited by 60 · see citing works
Self-citationMedvedev, A. E., Thomas, K., Awomoyi, A. A., Kuhns, D. B., Gallin, J. I., Li, X., & Vogel, S. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6587 · Cited by 49 · see citing works
Self-citationAutosomal recessive Interleukin-1 receptor-associated kinase 4 deficiency in fourth-degree relatives
Cárdenes, M., von Bernuth, H., García-Saavedra, A., Santiago, E., Puel, A., Ku, C., Emile, J., Pïcard, C., Casanova, J., Colino, E., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.012 · Cited by 49 · see citing works
Self-citationRokosz, L. L., Beasley, J. R., Carroll, C. D., Lin, T. H., Zhao, J., Appell, K. C., & Webb, M. L. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.883 · Cited by 49 · see citing works
De, S., Karim, F., Kiessu, E., Cushing, L., Lin, L.-L., Ghandil, P., Hoarau, C., Casanova, J., Puel, A., & Rao, V. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003831 · Cited by 47 · see citing works
Self-citationToll-like receptors (TLRs) and immune disorders
Akashi‐Takamura, S., & Miyake, K. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0477-4 · Cited by 45 · see citing works
Septicemia without Sepsis: Inherited Disorders of Nuclear Factor-kB-Mediated Inflammation
von Bernuth, H., Puel, A., Ku, C., Yang, K., Bustamante, J. C., Chang, H., Pïcard, C., & Casanova, J. (2005) · Clinical Infectious Diseases · doi:10.1086/431994 · Cited by 45 · see citing works
Self-citationTranscriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat
Li, M. D., Cao, J., Wang, S., Wang, J., Sarkar, S., Vigorito, M., Ma, J. Z., & Chang, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059582 · Cited by 44 · see citing works
Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
Xi, J., Zhang, R., Chen, K., Yao, L., Li, M., Jiang, R., Li, X., & Fan, L. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105848 · Cited by 45 · see citing works
Self-citationInherited human IRAK-4 deficiency: an update
Pïcard, C., von Bernuth, H., Ku, C., Yang, K., Puel, A., & Casanova, J. (2007) · Immunologic Research · doi:10.1007/s12026-007-0006-2 · Cited by 43 · see citing works
Self-citationIdentification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
Tumey, L. N., Boschelli, D. H., Bhagirath, N., Shim, J., Murphy, E. A., Goodwin, D., Bennett, E. M., Wang, M., Lin, L., Press, B., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.056 · Cited by 40 · see citing works
Li, Y.-W., Mo, X., Zhou, L., Li, X., Dan, X., Luo, X., & Li, A. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.02.019 · Cited by 40 · see citing works
Self-citationKar, S., Ukil, A., & Das, P. K. (2010) · European Journal of Immunology · doi:10.1002/eji.201040533 · Cited by 38 · see citing works
Functional assessment of the mutational effects of human IRAK4 and MyD88 genes
Yamamoto, T. S., Tsutsumi, N., Tochio, H., Ohnishi, H., Kubota, K., Kato, Z., Shirakawa, M., & Kondo, N. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.008 · Cited by 33 · see citing works
Kubo-Murai, M., Hazeki, K., Nigorikawa, K., Omoto, T., Inoue, N., & Hazeki, O. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm234 · Cited by 33 · see citing works
Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state
López‐Collazo, E., Fuentes‐Prior, P., Arnalich, F., & del Fresno, C. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224817.35105.7d · Cited by 31 · see citing works
Liu, W., & Shou, C. (2011) · Biological Research · doi:10.4067/s0716-97602011000400011 · Cited by 25 · see citing works
Zou, P., Huang, X. N., Yao, C.-L., Sun, Q. X., Li, Y., Zhu, Q., Yu, Z. X., & Fan, Z. J. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.12.019 · Cited by 24 · see citing works
Tang, X., Huang, B., Zhang, L., Li, L., & Zhang, G. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.02.004 · Cited by 23 · see citing works
Cai, H. X., Zhang, T., & Yuanjia, H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118055 · Cited by 22 · see citing works
Han, X., Gao, F., Lu, M., Liu, Z., Wang, M., Ke, X., Yi, M., & Cao, J. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.041 · Cited by 22 · see citing works
Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan
Zhao, L., Zhao, J., Dong, Z., Xu, S., & Wang, D. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.11.002 · Cited by 17 · see citing works
Emerging trends in IRAK-4 kinase research
Yadav, H. K., & Shirumalla, R. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08438-w · Cited by 15 · see citing works
Solving the IRAK-4 Enigma: Application of Kinase-Dead Knock-In Mice
Koziczak‐Holbro, M., Joyce, C., Glück, A., Kinzel, B., Müller, M. M., & Gram, H. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2007_071 · Cited by 12 · see citing works
Cui, Y., Jiang, L., Xing, R., Wang, Z., Wang, Z., Shao, Y., Zhang, W., Zhao, X., & Li, C. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.08.006 · Cited by 10 · see citing works
Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats
Pletinckx, K., Krings, D., Welbers, A., Rider, D. A., & Dunkern, T. R. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.035 · Cited by 10 · see citing works
Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity
Böl, G., Jurrmann, N., & Brigelius‐Flohé, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.121 · Cited by 10 · see citing works
MyD88-induced downregulation of IRAK-4 and its structural requirements
Hatao, F., Yamamoto, M., Muroi, M., Kaminishi, M., & Tanamoto, K. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00425.x · Cited by 9 · see citing works
New insights into the post-translational modification of Toll-like receptor signaling molecules
Dunne, A., & O'Neill, L. A. J. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110060701 · Cited by 9 · see citing works
Britan, A., Cusin, I., Hinard, V., Mottin, L., Pasche, E., Gobeill, J., de Laval, V. R., Gleizes, A., Teixeira, D., Michel, P.-A., et al. (2018) · Database · doi:10.1093/database/bay129 · Cited by 9 · see citing works
Peterson, J., Sivars, K. B., Bianco, A., & Röper, K. (2023) · Development · doi:10.1242/dev.201893 · Cited by 8 · see citing works
Hekmat-Nejad, M., Cai, T. Z., & Swinney, D. C. (2010) · Biochemistry · doi:10.1021/bi901609m · Cited by 8 · see citing works
Pattern recognition receptors: an update
Goutagny, N., & Fitzgerald, K. A. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.569 · Cited by 8 · see citing works
Vogt, L. M., Boekschoten, M. V., de Groot, P. J., Faas, M. M., & de Vos, P. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.011 · Cited by 8 · see citing works
Cloning and Characterization of DULP, a Novel Ubiquitin-Like Molecule from Human Dendritic Cells
Liu, G.-Y., Liu, S., Li, P., Tang, L. F. P., Han, Y., An, H., Li, J.-Y., Dai, X., Li, N., Cao, X., et al. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.4 · Cited by 6 · see citing works
Peng, Y., Peng, C.-T., Lin, Y., Lin, G., Huang, S., Chen, S., Sytwu, H., & Cheng, C.-P. (2020) · Mediators of Inflammation · doi:10.1155/2020/1237281 · Cited by 4 · see citing works
Han, R., Wang, J.-L., Chen, H., Luo, X., Li, A., Dan, X., & Li, Y. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.09.011 · Cited by 3 · see citing works
PROteolysis TArgetting Chimeras (PROTACs) Strategy Applied to Kinases: Recent Advances
Feral, A., Laconde, G., Amblard, M., & Masurier, N. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000148 · Cited by 3 · see citing works
Chen, Y., Sun, D., Yang, R., Lim, J., Sondey, C., Presland, J. P., Rakhilina, L., Addona, G. H., Kariv, I., & Chen, H. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211021074 · Cited by 2 · see citing works
The Latest Advancements of the PROTACs Based on CRBN E3 Ligase for Cancer Treatment
Stadnichenko, V. O., Borysko, P., & Tolstanova, G. M. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00409-y · Cited by 2 · see citing works
Proinflammatory Chemical Signaling: Cytokines
Nagamoto‐Combs, K., & Combs, C. K. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_6 · Cited by 2 · see citing works
Synthesis and in vitro characterization of novel IRAK-4 inhibitor compounds
Shrivastava, D., Gupta, L. K., Yerrapureddy, A., & Nune, S. S. K. (2026) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2026.2620804 · Cited by 1 · see citing works
Dickkopf1 is a novel endogenous ligand for priming NLRP3 inflammasome in macrophages via TLR4
Aung, T., Song, S., Kasongo, J., Harada, H., Zhang, S., Henegariu, O., & Chae, W. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf367 · Cited by 1 · see citing works
Stimulated protein degradation to promote mitochondrial function and neuronal survival
Chandrasekhar, S., McMinimy, R. A., Manford, A. G., Wehri, E., Gee, C. L., Miller, C., Bingol, B., Kuriyan, J., Schaletzky, J., & Rapé, M. (2026) · Science · doi:10.1126/science.aed2525 · Cited by 1 · see citing works
Life-Saving Degeneracy in the Human Immune System
Brodin, P. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.02.018 · Cited by 1 · see citing works
IRAK-4: A key kinase involved in toll-like receptor signaling and resistance to bacterial infection
Medvedev, A. E., Kuhns, D. B., Gallin, J. I., & Vogel, S. N. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_9 · Cited by 1 · see citing works
Toll‐Like Receptors in Atherosclerosis
Yan, Z.-Q., Edfeldt, K., & Lundberg, A. M. (2010) · Atherosclerosis · doi:10.1002/9783527629589.ch5
Bäckström, E. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
- Authors
- Qin, J., Jiang, Z., Qian, Y., Casanova, J.-L., & Li, X.
- Affiliations
- Cleveland State University (US)
- Cleveland Clinic (US)
- Inserm (FR)
- Corresponding author
- Li, Xiaoxia
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 25
- Pages
- 26748-26753
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1964985092
- Cited by
- 110
- References
- 27
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 8 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM 60020, R01GM060020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- IRAK4, IRAK, IL-1 signaling, IL-1 receptor, kinase redundancy, transphosphorylation, autophosphorylation, NF-κB activation, JNK activation, IL-8 expression
- MeSH terms
- Cell Line, Dose-Response Relationship, Drug, Enzyme Activation, Fibroblasts, Genetic Complementation Test, Humans, Interleukin-1, Luciferases, Models, Biological, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Time Factors, Transfection, Blotting, Northern, Blotting, Western, Interleukin-8, NF-kappa B, Receptors, Interleukin-1, Phosphotransferases (Alcohol Group Acceptor), Genes, Reporter, E-Selectin, Mitogen-Activated Protein Kinase Kinases, Ubiquitin, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Interleukin-1 Receptor-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
